Business Context and Reporting Period
This Form 8-K Current Report was filed by P3 Health Partners Inc. on July 9, 2025, covering events occurring on July 2, 2025. The filing addresses changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignation: Dr. Sherif Abdou resigned from the Board of Directors effective July 2, 2025. His transition services agreement had previously expired on April 30, 2025.
- Appointment: The Board unanimously approved the appointment of Dr. Aric Coffman to fill the vacancy on July 8, 2025.
- Director Status: Dr. Coffman will serve as a Class I director with a term expiring in 2028. He is not considered an independent director due to his role as Chief Executive Officer and will not serve on Board committees.
- Compensation: Dr. Coffman will not receive additional compensation for his service on the Board.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Dr. Sherif Abdou's resignation is effective immediately as of July 2, 2025.
- Dr. Aric Coffman (CEO) has been appointed to the Board but is not an independent director.
- The appointment was approved by the Board on July 8, 2025, following a unanimous recommendation by the Nominating Committee.
- No additional compensation is being paid to Dr. Coffman for his board service.